This paper demonstrates the potential for utilizing the plant enzyme, horseradish peroxidase ( HRP ) , in a gene -directed enzyme prodrug therapy context. Human T24 bladder carcinoma cells transfected with a mammalian expression vector containing the HRP cDNA were selectively sensitized to the nontoxic plant hormone, indole -3 -acetic acid ( IAA ) . The HRP / IAA -induced cell kill was effective in normoxic and anoxic conditions. The activated drug is a long -lived species able to cross cell membranes, and cell contact appears not to be required for a bystander effect to take place. These preliminary results suggest that the delivery of the HRP gene to human tumors followed by IAA treatment may provide a novel cancer gene -directed enzyme prodrug therapy approach, with potential to target hypoxic cells.
G ene -directed enzyme prodrug therapy (GDEPT ) consists of a two-phase molecular chemotherapy. Firstly, a gene encoding a foreign enzyme is delivered to the target cells; secondly, a prodrug is administered and selectively converted to a cytotoxin by the enzyme synthesized at the target. To obtain specificity, therapeutic gene expression can be regulated by tumor-specific or tumor condition -specific promoters (reviewed in Ref. 1 ). The most well -known example of enzyme/ prodrug combination in cancer GDEPT is the herpes simplex virus thymidine kinase (HSV TK ) /ganciclovir ( GCV ) 2 currently adopted in clinical trials. 3 Because activated GCV interferes with DNA synthesis, the HSV TK /GCV system is particularly suitable for the eradication of rapidly dividing tumor cells invading nonproliferating tissue. However, it is not the combination of choice to target the slowly dividing hypoxic population in solid tumors, 4, 5 which has been shown to contribute to resistance of human tumors to chemotherapy and radiotherapy (reviewed in Ref. 6 ). The horseradish peroxidase ( HRP ) and the plant hormone, indole-3-acetic acid (IAA ), represent a novel enzyme/ prodrug combination, with potential for hypoxia -regulated gene therapy. 7 When reacting with IAA, HRP does not require hydrogen peroxide and is characterized by a different substrate specificity and reaction pathway from the mammalian myeloperoxidase. 8, 9 At neutral pH, IAA is oxidized by HRP compound I to a radical cation, which undergoes scission of the exocyclic carbon ± carbon bond to yield the carbon -centered skatolyl radical 8 ( Fig 1:2,3 ). In the presence of oxygen, the skatolyl radical rapidly forms a peroxyl radical ( Fig 1:4 ) , which then decays to a number of products, the major ones being indole -3 -carbinol, oxindole -3 -carbinol, and 3-methylene -2 -oxindole 8 ( Fig 1:5 ) . In anoxic solution, decarboxylation of the radical cation can still take place and the carbon -centered radical preferentially reacts with hydrogen donors 10, 12 (Fig 1 ) . When activated by purified HRP, IAA was shown to inhibit colony formation in mammalian cells, whereas, neither enzyme nor prodrug alone was cytotoxic at the same concentration or times. 11, 13 Endogenous peroxidases in human tumor cells 13 and rat leukocytes and phagocytes 14 were significantly less efficient in converting IAA into a cytotoxin. Moreover, no major toxicity has been observed in patients after oral administration of 100 mg /kg IAA. 15 The aim of the current study was to determine the potential of utilizing the HRP -encoding gene for cancer GDEPT. Human tumor cells were transfected in vitro with the HRP cDNA and their sensitization to IAA was evaluated in normoxic and anoxic conditions. The ability of the HRP /IAA combination to induce a bystander effect was also studied.
MATERIALS AND METHODS

Cell culture
Human bladder carcinoma T24 cells ( European Collection of Cell Cultures, Salisbury, UK ) were maintained in Dulbecco's modified Eagle's medium (DMEM, Life Technologies, Paisley, UK ) supplemented with 10% fetal calf serum ( Sigma, Gillingham, UK ), 2 mM L -glutamine (Life Technologies ), 100 U / mL penicillin (Sigma ), 100 g/mL streptomycin ( Sigma ), and incubated in a humidified incubator at 378C and 5% CO 2 /air. For experiments in anoxic conditions, cells were incubated in an anaerobic glove cabinet (Don Whitley Scientific, Shipley, UK ) with 5% CO 2 , 5% H 2 , 90% N 2 and palladium catalyst at 378C. Only cells which tested negative for mycoplasma infection were utilized.
Plasmid DNA and cell transfection
The plasmids, pRK34 -HRP 16 and pCI-TK, 17 were kindly provided by Dr. D.F. Cutler ( UCL, London) and Dr. S.D. Scott (Gray Laboratory) . The constructs of pCI-EGFP were made as follows to contain an identical vector backbone as pCI-TK: the enhanced green fluorescent protein (EGFP ) gene was excised from pEGFP -N1 (Clontech, Basingstoke, UK ) by EcoRI /NotI digestion ( enzymes from Life Technologies ) and the resulting fragment inserted in the commercial vector pCI -neo ( Promega, Southampton, UK ) , linearized with the same restriction enzymes. The sequence integrity of the plasmids was confirmed using a Thermo Sequenase Cycle Sequencing Kit (Amersham Pharmacia Biotech, Amersham, UK ) and Gene Readir DNA Analyzer ( LI-COR, Lincoln, NE ).
Transient transfectants were obtained by exposing T24 cells to complexes of integrin -targeted peptides (Dr. S.L. Hart, ICH, London, U.K.), Lipofectin (Life Technologies ) and DNA as described previously, 18 and were assayed for gene expression after 24 hours.
Transfection efficiency with the plasmid pRK34 -HRP was analyzed by immunofluorescence analysis (see Immunofluorescence staining ). Transfection efficiency with the construct pCI-TK was estimated by measuring the production of the marker protein EGFP in cells transfected under the same conditions with pCI-EGFP. Intracellular EGFP ( excitation maximum, 488 nm; emission maximum, 507 nm ) was detected by fluorescence -activated cell sorting ( FACS ) on a Becton Dickinson FACScan. Cells were scored as positive if they showed an increased fluorescence with respect to untransfected cells.
Immunofluorescence staining
Antibody staining on paraformaldehyde -fixed transfected and untransfected T24 cells was carried out as reported previously. 19 Rabbit polyclonal anti -HRP ( Dako, Ely, UK ) diluted 1:200 was used as the primary antibody; TRITCconjugated swine antirabbit immunoglobulins (Dako ) were diluted 1:200 as secondary antibodies. Slides were viewed using an Olympus BH -2 fluorescence microscope. Alternatively, to measure the transfection efficiency with the plasmid pRK34 -HRP, cell suspensions were FACS -analyzed after immunostaining.
HRP activity assay
The HRP activity was analyzed using a modified 3,3 H ,5,5 Htetramethylbenzidine dihydrochloride assay. Transfected and untransfected cells were harvested and resuspended in 0.5% hexadecyltrimethylammonium bromide ( Sigma ) in 50 mM phosphate buffer (pH 6.0 ). Cells were lysed by ( 1 ) is oxidized by HRP to the radical cation ( 2 ) , which fragments rapidly to yield the skatolyl radical ( 3 ) . In anoxia, this probably forms adducts, e.g., with DNA. 10 Otherwise, the skatolyl radical promptly reacts with oxygen to form the peroxyl radical ( 4 ) , which, via a hydroperoxide and reduction / rearrangement, forms 3 -methylene -2 -oxindole ( 5 ) . The latter can react with cellular nucleophiles ( Nu ) , e.g., protein thiols, and DNA to form adducts. freezing/ thawing three times in liquid nitrogen at 378C and by centrifugation in a microfuge for 15 minutes at 13,000 rpm. Enzyme reactions were carried out at room temperature by diluting 20 L supernatant in 80 mM phosphate buffer ( pH 5.4) , 3.2 mM 3,3
H -tetramethylbenzidine dihydrochloride ( Sigma) , 3.0 mM H 2 O 2 in a total volume of 2 mL. Absorbance at 652 nm ( A652 ) was read at room temperature over 60 minutes at 1 -minute intervals on a Hewlett Packard model 8452A diode array spectrophotometer. The total cellular protein content in the samples was determined by using a commercial protein assay kit ( Lowry procedure, Sigma) . The HRP activity was expressed as the absorbance measured after 60 min / g of total cellular protein in the sample.
The HRP content in transfected cells was also evaluated. The A652 rate of increase up to 10 minutes (linear least square regression ) and the A652 at 60 minutes were estimated and compared to calibration curves obtained with purified HRP ( results not shown ). The HRP content was then normalized to the total protein content in the sample.
Western blotting
Western blotting analysis of HRP protein was conducted as previously described. 20 Briefly, cell monolayers were resuspended in Laemmli sample buffer and whole cell extracts were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis ( 12% polyacrylamide gels, ProtoGel, National Diagnostic, Atlanta, GA ) . Proteins in the gel were transferred to nitrocellulose membranes ( Genetic Research Instrumentation, Rayne, UK ) using an LKB -Pharmacia semidry blotter. Immunoblotting was performed with primary rabbit polyclonal anti -HRP antibodies and secondary HRP -conjugated goat antirabbit immunoglobulins (Dako ) . Detection of immunoreactive bands was performed using the enhanced chemiluminescence technique (ECL kit, Amersham Pharmacia Biotech) .
Clonogenic assays
Exponentially growing transfected and untransfected cells were plated at low density on Petri dishes and exposed to IAA ( Aldrich, Gillingham, UK ) , with or without 1.2 g/mL HRP, or GCV (from Dr. E. Littler, GlaxoWellcome, Stevenage, UK ) for 2 or 24 hours in phenol red ± free Hanks' balanced salt solution (HBSS, Life Technologies ) in the 378C incubator.
Alternatively, cells were preplated in the anaerobic cabinet and, after incubation for 5 ±6 hours, were exposed to the prodrugs for 2 or 24 hours in anoxic conditions. All plastics and media were preincubated in anoxia for 48 hours before use to remove residual oxygen.
In conditioned medium -switch experiments, HBSS containing a range of concentrations of IAA was transferred after a 2 -hour incubation with transient transfectants to preplated untransfected cells and left to react for 2 hours with the cell monolayers.
Following drug exposure, cells were rinsed with PBS and grown for 10 days in complete DMEM supplemented with feeder cells ( V79 cells exposed to 250 Gy 60 Co irradiation ) . After fixation and staining with 2.5% wt /vol crystal violet ( Sigma ) in isomethylated spirit, colonies of > 50 cells were scored. Surviving fractions were evaluated relative to HBSS-treated controls. The concentration of prodrug required to reduce cell survival by 50% (IC 50 ) was estimated from the survival curves.
RESULTS
Cytotoxicity of IAA activated by purified HRP in human cells
In our GDEPT strategy, we aim to sensitize the target cells to the prodrug IAA activated by the enzyme HRP. Consequently, human bladder carcinoma T24 cells were exposed for time intervals from 15 minutes to 2 hours to 0.1 mM IAA and 1.2 g /mL purified HRP. Clonogenic assays showed a decrease in surviving fraction with increased exposure time (Fig 2 ) . The cells were also exposed to the enzyme and prodrug independently and no significant cytotoxic effects were observed at the concentration /time indicated (Fig 2) .
Transfection of human cells with the HRP -encoding gene
The T24 cells were transiently transfected with the pRK34 -HRP plasmid and 20± 26% transfection efficiency was observed from immunostaining followed by FACS analysis.
Immunolabeling for HRP protein in transfectants is shown in Figure 3A . HRP is evident in the cytoplasm and the nuclear membrane. This is consistent with the fact that in the pRK34 -HRP construct, the HRP cDNA had been previously fused to the signal sequence from the human growth hormone and the KDEL retention motif, 16 allowing the HRP to be accumulated in the endoplasmic reticulum and the nuclear envelope. Untransfected cells and EGFPexpressing cells did not stain positive for HRP (results not shown) . Synthesis of an immunoreactive protein of correct size (about 52 kDa ) was confirmed by Western blotting (Fig 3B) .
Increase in peroxidase activity of 60-fold was observed in HRP transfectants compared to untransfected T24 cells ( Fig  3C ) . An HRP content of 18 1 pg/ g total cellular protein was estimated in transfectants.
In vitro efficacy of the HRP / IAA system Figure 4 shows the effect of increasing IAA concentration on clonogenicity of transfected and untransfected T24 cells. After only 2 -hour prodrug incubation under normoxic or anoxic conditions, increased cytotoxicity in HRP -expressing cells was detected (Fig 4A ) . At nontoxic doses of IAA, one -to two-log cell kill was induced in HRP -positive cells, even though only 20 ±26% of the transient transfectants was shown to synthesize the foreign enzyme. Expression of the HRP gene per se did not affect the transfectants, as judged by plating efficiency, proliferation rate, or microscopic appearance in the absence of IAA ( results not shown ). Cells transiently transfected with the plasmid, pEGFP -N1, incubated with IAA gave the same response as the untransfected population (data not shown) .
Cancer Gene Therapy, Vol 7, No 11, 2000 GRECO, FOLKES, WARDMAN, ET AL: NOVEL ENZYME/PRODRUG COMBINATION FOR CANCER GDEPT IAA doses above 4 mM produced a significant decrease of the medium pH affecting cell survival, and therefore were not included in the survival curves. When the medium pH was adjusted to 7.4, no toxicity was detected in untransfected T24 cells exposed for 2 hours to up to 20 mM IAA ( results not shown ).
A higher efficacy of the HRP /IAA system was observed after 24 -hour incubation (Fig 4B ) . In HRP -expressing cells, 95% colony inhibition was induced at doses of IAA around 1 mM. A 28-fold increase in cytotoxicity in air and a 50 -fold increase in anoxia were estimated for transfected compared to untransfected cells, as assessed by equivalent doses to reduce surviving fraction to 50% (IC 50 ).
Anoxic incubation did not reduce the efficacy of the system. The shape of the anoxic survival curves and the IAA activation pathway 8, 12 suggest that different toxic metabolites may be involved in the induced cell death.
IAA -containing medium, preconditioned by transfected cells, reduced the clonogenicity of untransfected cells (Fig 4A ) , suggesting a potential bystander effect of this approach.
Cytotoxicity of the HSV TK / GCV combination in T24 cells
In order to compare the novel HRP / IAA combination with an established enzyme /prodrug system, T24 cells were transiently transfected with the HSV TK gene and exposed to GCV. From parallel transfections with the plasmid pCI-EGFP, a transfection efficiency of 60 ± 70% was estimated. After a 2 -hour incubation with GCV, no reduced survival was detected in TK -expressing cells compared to the untransfected population (Fig 5A ) . When the prodrug GCV was left to react for 24 hours with the cell monolayers, a 4-fold increase in cytotoxicity ( IC 50 ) was induced in oxic TK transfectants ( Fig 5B ) . In anoxic conditions, no selective cytotoxicity could be measured at any dose of GCV tested ( up to 5 mM ) (Fig 5B ) . Doses above 1 mM GCV appeared to be toxic in the untransfected cells under both oxic and anoxic conditions.
DISCUSSION
This preliminary report demonstrates the potential for utilizing HRP and IAA as a novel enzyme/ prodrug combination for cancer gene therapy.
The efficacy of the HRP / IAA system was evaluated in vitro by exposing human tumor T24 cells transiently transfected with an expression vector containing the HRP cDNA to the prodrug IAA. Significant cytotoxicity could be evoked after 2-hour exposure and was further increased after 24 -hour incubation. Up to two -log cell kill was induced at nontoxic doses of IAA. In order to investigate the potential of the HRP /IAA combination to kill the hypoxic subpopulation in solid tumors, transfectants were exposed to IAA in an oxygen -free atmosphere. These extreme tumor conditions did not reduce the efficacy of the system and significant cell kill was measured.
Different IAA metabolites may be produced in oxic and anoxic cells. In the absence of oxygen, the peroxyl radical and its decay products cannot be formed, but the skatolyl radical can 12 (Fig 1:3 ) . Skatolyl -type radicals readily abstract hydrogen from donor molecules and have been shown to react with biomolecules such as DNA. 11 They could therefore lead to cell damage by the formation of secondary radicals in key biological targets. In normoxic cells, however, skatolyl radicals are more likely to react with oxygen to form peroxyl radicals. 11 Prompt attack by radicals on cellular targets in air may be ruled out because conditioned medium -switch experiments (Fig 4A ) and incubation of mammalian cells with filtered products of IAA oxidation 13 indicate that the toxic agent is a stable long -lived species. Of the stable products, indole -3 -carbinol is nontoxic to V79 cells at experimentally produced concentrations, with or without HRP. 21 3 -Methylene -2-oxindole ( Fig  1:5 ) has been reported to be toxic in Esherichia coli and some plants, to react with glutathione, and to bind to sulfhydryl regions of histone DNA or RNA. 21 The role of 3-methylene -2 -oxindole in the HRP /IAA -induced toxicity is currently under investigation.
The shape of the survival curves also suggests that different cytotoxic mechanisms could be induced at low and high concentrations of IAA and that the threshold dose for the second pathway to prevail is reached more rapidly in the presence of oxygen (Fig 4 ) . Further work is under way to identify the toxic species and the critical cellular targets at different oxygen concentrations. To date, lipid peroxidation observed in liposome models 22 could not be detected in mammalian cells exposed to oxidized IAA, whereas, incubation of plasmid DNA with the activated drug resulted in the formation of DNA adducts and strand breaks. 11 Our studies suggest that the HRP /IAA system can produce a bystander effect. In all experiments, HRPexpressing cells were estimated to represent about a quarter of the population exposed to IAA, but this mixed population could be almost completely eradicated (Fig 4 ) . This bystander effect does not appear to require cell contact, unlike HSV TK / GCV, 23 because the cells were sparsely seeded in order to avoid cell ± cell adhesion during drug exposure and colony formation. Moreover, incubation of HRP -negative cells with preactivated IAA resulted in cell death (Fig 4A ) , indicating that the observed bystander phenomenon was due to the transfer of a soluble toxic compound able to cross cell membranes.
It is important to note that the cell line utilized in this study is known to be resistant to a number of chemotherapeutic drugs. 24 Moreover, T24 cells are characterized by a p53 nonsense mutation at codon 126 that appears to be involved in resistance to apoptosis induced by DNAdamaging agents. 25 This cell line was also more resistant to IAA when activated by purified HRP (Fig 2 ) compared to the mammalian cells used in previous studies. 11, 13 After 2-hour exposure to 0.1 mM IAA activated by 1.2 g/mL HRP, 87% of T24 cells lost their clonogenic potential, whereas, at the same concentration/ time, a two -log cell kill was induced in V79 cells. 11, 13 The low apoptotic potential of the T24 cells may also explain their poor response to HSV TK /GCV, which had been demonstrated to induce programmed cell death. 23 After 24-hour incubation, only a 4 -fold increase in cytotoxicity (IC 50 ) was induced in air, and no selective sensitization could be detected in anoxic TK -expressing T24 cells. In previous studies, 2, 23 at least a three -log increase in cytotoxicity has been detected when transfected mammalian cells were grown for 5 ±14 days in the presence of GCV.
This preliminary in vitro study showed that the HRP /IAA system has the potential for use in cancer gene therapy and that in vivo testing is now warranted. Taken collectively, these observations support the further development of this GDEPT approach. thank Dr. Chryso Kanthou, Claudia Coralli, and Angela Holder for technical assistance, Dr. Luis Candeias and Dr. Maja Cemazar for helpful discussions.
